Showing 2031-2040 of 2657 results for "".
- American Academy of Optometry Announces 2023 New Fellows and Diplomateshttps://modernod.com/news/american-academy-of-optometry-announces-2023-new-fellows-and-diplomates/2481910/The American Academy of Optometry recently hosted Academy 2023 New Orleans from October 11-14, 2023. During the organization’s annual meeting, the Academy welcomed 257 new fellows to its ranks. Along with this strong showing of new fellows, 12 current fellows earned the distinction of
- Endogena Therapeutics Secures FDA Green Light to Initiate Trials for Geographic Atrophy Treatmenthttps://modernod.com/news/endogena-therapeutics-secures-fda-green-light-for-breakthrough-amd-treatment/2481909/Endogena Therapeutics announced that the FDA has granted clearance for Endogena's investigational new drug (IND) application, allowing the company to commence a first-in-human study in 2024 for its geographic atrophy drug cadidate EA 2351. This milestone marks the com
- Stuart Therapeutics Enters License Agreement with Glaukos for Preclinical Glaucoma Drug Candidatehttps://modernod.com/news/stuart-therapeutics-enters-license-agreement-with-glaukos-for-preclinical-glaucoma-drug-candidate/2481904/Stuart Therapeutics has entered into a license agreement with Glaukos under which it has granted Glaukos exclusive worldwide rights to develop and commercialize Stuart's proprietary ST-113 drug candidate for neuroprotection in glaucoma. ST-113 is a pat
- Haag-Streit Announces Launch of Haag-Streit Japanhttps://modernod.com/news/haag-streit-announces-launch-of-haag-streit-japan/2481899/In a move to solidify its regional presence following recent expansions into China and Singapore, Haag-Streit announced the establishment of Haag-Streit Japan KK. "Our expansion into Japan is a milestone in Haag-Streit’s international commercial expansion plan,
- Bausch + Lomb Launches enVista Aspire Monofocal and Toric IOLshttps://modernod.com/news/bausch-lomb-launches-envista-aspire-monofocal-and-toric-iols/2481897/Bausch + Lomb announced the launch of the enVista Aspire monofocal and toric IOLs in the United States. The enVista Aspire IOLs featured B+L's Intermediate Optimized (IO) optics, which are designed for a broader depth of focus, with the benefits of the enVista platform to address patient
- SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Diseasehttps://modernod.com/news/splicebio-enters-collaboration-with-spark-therapeutics-to-develop-a-gene-therapy-targeting-an-inherited-retinal-disease/2481894/SpliceBio has announced the signing of an exclusive collaboration and licensing agreement with Spark Therapeutics to utilize SpliceBio’s proprietary Protein Splicing platform to develop a gene therapy for an undisclosed inherited retinal disease. Under the terms of
- BioTissue Presents New Data for Cryopreserved Amniotic Membrane Therapyhttps://modernod.com/news/biotissue-presents-new-data-for-cryopreserved-amniotic-membrane-therapy/2481880/Findings of a new multicenter, retrospective study conducted on patients with moderate to severe dry eye disease (DED) treated with BioTissue’s self-retained Prokera Slim Amniotic Membrane corneal bandage show significantly improved patient outcomes in less time, according to
- Prevent Blindness to Host “World Sight Day” Congressional Briefing and Free Vision Screening on Capitol Hillhttps://modernod.com/news/prevent-blindness-to-host-world-sight-day-congressional-briefing-and-free-vision-screening-on-capitol-hill/2481872/Nonprofit Prevent Blindness will be hosting a Congressional Briefing and free vision screening on October 12 from 10 am to 2 pm ET. The event, with support from the Prevention of Blindness Society of Metropolitan Washington, is part of this year’s
- Optometry Giving Sight Sets $500,000 Fundraising Goal for the 2023 World Sight Day Challengehttps://modernod.com/news/optometry-giving-sight-sets-500000-fundraising-goal-for-the-2023-world-sight-day-challenge/2481868/Optometry Giving Sight (OGS) has announced a $500,000 fundraising goal for its 2023 World Sight Day Challenge. Donations will fuel the organization’s efforts to help eradicate uncorrected refractive error through the growth and expansion of optometry around the world. The the
- Humonix Biosciences Launches 3D Human Tissue Modelhttps://modernod.com/news/specialty-pharmaceutical-research-company-humonix-biosciences-launches-3d-human-tissue-model/2481864/Humonix Biosciences has developed a new 3D human tissue model called the retinal vascular dysfunction model. Humonix’s new model is a physiologically relevant 3D model of the blood-retinal barrier. This model expresses key physiological and biological characteristics, providing a platf